Asker Healthcare Group Overview
- Year Founded
-
2006
- Status
-
Public
- Employees
-
4,898
- Stock Symbol
-
ASKER
- Investments
-
41
- Share Price
-
$7.08
- (As of Thursday Closing)
Asker Healthcare Group General Information
Description
Asker Healthcare Group AB is a provider of medical products and solutions that drive progress in the European healthcare sector. The company is engaged in building and acquiring companies to support the healthcare system to improve patient outcomes, reduce the total cost of care, and ensure a fair and sustainable value chain. The company also offers a range of value-added solutions to support its suppliers and customers in, for example, market access, efficiency, and sustainability. Company has adapted a twin engine growth strategy that combines organic and acquired growth. Geographically, the company evaluates the operations in three business areas: North, West and Central.
Contact Information
Website
www.asker.comCorporate Office
- Svärdvägen 3A
- 182 33 Danderyd
- Sweden
Corporate Office
- Svärdvägen 3A
- 182 33 Danderyd
- Sweden
Asker Healthcare Group Timeline
Asker Healthcare Group Stock Performance
As of 19-Nov-2026, Asker Healthcare Group’s stock price is $7.08. Its current market cap is $2.71B with 383M shares.
(As of Thursday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $7.08 | $7.05 | $5.77 - $9.87 | $2.71B | 383M | 774K | $0.21 |
Asker Healthcare Group Financials Summary
As of 30-Sep-2026, Asker Healthcare Group has a trailing 12-month revenue of $1.98B.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 3,120,476 | 4,017,827 | ||
| Revenue | 1,983,632 | 1,708,649 | 1,420,678 | 1,265,676 |
| EBITDA | 133,136 | 170,590 | 138,049 | 105,089 |
| Net Income | 80,456 | 50,078 | 34,040 | 19,099 |
| Total Assets | 1,891,326 | 1,822,880 | 1,188,925 | 1,133,287 |
| Total Debt | 697,768 | 631,825 | 539,901 | 497,602 |
Asker Healthcare Group Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Asker Healthcare Group Comparisons
Industry
Financing
Details
Asker Healthcare Group Competitors (5)
One of Asker Healthcare Group’s 5 competitors is Revelation Pharma, a Private Equity-Backed company based in Kennesaw, GA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Revelation Pharma | Private Equity-Backed | Kennesaw, GA | ||||
| Sekhmet Pharmaventures | Private Equity-Backed | Mumbai, India | ||||
| Foundation Consumer Brands | Private Equity-Backed | Pittsburgh, PA | ||||
| HCA Healthcare UK | Corporation | London, United Kingdom | ||||
| China Healthcare Acquisition | Corporation | Pasadena, CA |
Asker Healthcare Group Patents
Asker Healthcare Group Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| DE-2227088-A1 | Pack for the treatment of flavoring media | Inactive | 21-Oct-1968 |
Asker Healthcare Group Signals
Asker Healthcare Group Investments & Acquisitions (41)
Asker Healthcare Group’s most recent deal was a Merger/Acquisition with Teresa. The deal was made on 03-Nov-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Teresa | 03-Nov-2026 | Merger/Acquisition | Medical Supplies | ||
| Labo Clinic | 02-Sep-2026 | Merger/Acquisition | Distributors (Healthcare) | ||
| Med Kjemi | 01-Sep-2026 | Merger/Acquisition | Distributors (Healthcare) | ||
| AmberCell Solutions | 19-Aug-2026 | Merger/Acquisition | Distributors (Healthcare) | ||
| Murray Surgical | 03-Jul-2026 | Merger/Acquisition | Distributors (Healthcare) |
Asker Healthcare Group ESG
Risk Overview
Risk Rating
Updated November, 17, 2026
11.9 | Low Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,592
Rank
Percentile
Healthcare
Industry
of 590
Rank
Percentile
Medical Distribution
Subindustry
of 42
Rank
Percentile
Asker Healthcare Group Affiliates
Subsidiaries (27)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| InnoMedicus | Cham, Switzerland | 2021 | |
| Novus Med | Kenilworth, United Kingdom | 2016 | |
| AmberCell Solutions | Klaipėda, Lithuania | 2011 | |
| Aspironix | Prague, Czech Republic | 2011 | |
| Cardio Dépôt | Castagniers, France | 2011 |
Asker Healthcare Group FAQs
-
When was Asker Healthcare Group founded?
Asker Healthcare Group was founded in 2006.
-
Where is Asker Healthcare Group headquartered?
Asker Healthcare Group is headquartered in Danderyd, Sweden.
-
What is the size of Asker Healthcare Group?
Asker Healthcare Group has 4,898 total employees.
-
What industry is Asker Healthcare Group in?
Asker Healthcare Group’s primary industry is Holding Companies.
-
Is Asker Healthcare Group a private or public company?
Asker Healthcare Group is a Public company.
-
What is Asker Healthcare Group’s stock symbol?
The ticker symbol for Asker Healthcare Group is ASKER.
-
What is the current stock price of Asker Healthcare Group?
As of 19-Nov-2026 the stock price of Asker Healthcare Group is $7.08.
-
What is the current market cap of Asker Healthcare Group?
The current market capitalization of Asker Healthcare Group is $2.71B.
-
What is Asker Healthcare Group’s current revenue?
The trailing twelve month revenue for Asker Healthcare Group is $1.98B.
-
Who are Asker Healthcare Group’s competitors?
Revelation Pharma, Sekhmet Pharmaventures, Foundation Consumer Brands, HCA Healthcare UK, and China Healthcare Acquisition are competitors of Asker Healthcare Group.
-
What is Asker Healthcare Group’s annual earnings per share (EPS)?
Asker Healthcare Group’s EPS for 12 months was $0.21.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process